BioSpace News Archive

Chiesi Farmaceutici S.p.A. and Apotex, Inc. announced that Chiesi Group has finalized an agreement for the acquisition of the worldwide rights to Ferriprox®.

Xenon’s Proprietary Programs Continue to Advance with Multiple Mid to Late Stage Clinical Trials Anticipated to be Underway in 2020

The National Institutes of Health’s All of Us Journey is visiting Baton Rouge January 16-22 to educate the community about the opportunity to participate in a historic medical research effort.

Neogen Corporation announced that it has acquired Italy-based Diessechem S.R.L. — a distributor of food and feed safety diagnostics for the past 27 years..

Delcath Systems, Inc. announced it has completed patient enrollment in its FOCUS registration trial intended to confirm the potential of its investigational combination treatment for patients with unresectable hepatic-dominant metastatic ocular melanoma.

Health Authorities in the U.S. and U.K. Clear Path to Start of Clinical Trial, Patients Expected to be Dosed in Q1 2020 with Commercial Scale Material

NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced preliminary unaudited revenue results for the fourth quarter and full year 2019.

ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, announced that Dr. Steve Cutler, CEO and Mr. Brendan Brennan, CFO of ICON plc, will present at 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020.

Lantheus Holdings, Inc., parent company of Lantheus Medical Imaging, Inc., a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, announced the appointment of Istvan Molnar, M.D. as Chief Medical Officer, effective January 6, 2020.

Full-Body MRI-Conditional InterStim II and InterStim Micro Systems Offer Lifestyle-Friendly Choices in Sacral Neuromodulation Therapy to Europeans Suffering from Incontinence